Clearing 2026 now open

Contact us todayContact us today

New courses now available in Chesterfield

View coursesView courses

£500 off selected accommodation

Explore HallsExplore Halls
Staff profile

Dr Olubukola T. Oyebode


She/Her

Lecturer in Biomedical Science

Academic unit

College of Science and Engineering

ORCiD ID

0000-0002-5323-3743

Email

O.Oyebode@derby.ac.uk

About

I am a lecturer in Biomedical Sciences specialising in cell death regulation and cancer therapy. Since 2012, I have worked in various higher education settings, contributing to both teaching and research. I have had the privilege of teaching biochemistry and cancer biology to diverse cohorts including medical, dental, and health sciences students at several institutions. As a biochemist and cancer biologist, I have led numerous research projects that explore effective approaches to modulating cell death in various disease conditions e.g diaetes, aging , cancer etc. These projects aim to elucidate the role of regulatory proteins in cell death pathways, enhancing our understanding of disease causation and strategic targeting.

Additionally, my research investigates natural compounds capable of modulating pathways involving  identified therapeutic targets, thereby offering potential new avenues for treatment. Alongside my research, I am committed to high-quality teaching, student mentorship, and collaborative interdisciplinary research.

Teaching responsibilities

Professional interests

My research interests centre on cancer biology, molecular and cellular mechanisms of disease, and translational biomedical research, with a focus on signalling pathways, metabolism, autophagy, ferroptosis, and therapeutic responses. I am particularly interested in identifying novel therapeutic targets and advancing collaborative research that connects basic science with clinical applications.

Research interests

My research spans cancer biology, mitochondrial biochemistry, and toxicology, unified by a central focus on how metabolic and signalling disruptions regulate cell death pathways and contribute to disease. Her work investigates both the therapeutic potential of targeting these pathways and the risks posed by agents that disrupt them. I’m paerticularly  interested in how different cell death pathways might cross-talk with each other, and how this knowledge could be used to develop new therpaeutic  strategies in dysregulated cell death.

My doctoral research explored the therapeutic manipulation of mitochondrial-mediated cell death for the treatment of cancer using naturally occurring bioactive agents isolated from Calliandra portoricensis. This study proposed the first molecular mechanism by which bioactive agents from this plant induce apoptotic cell death in prostate cancer cell lines. My postdoctoral training at the University of Tübingen in Germany expanded this research to explore additional cell death pathways mediated by bioactive compounds purified from this plant.

Currently, I am passionate about and engaged in projects that utilize non-pharmacological interventions, specifically Branched Chain Amino Acids, to investigate the mechanisms of ferroptosis sensitivity in triple-negative breast cancer (TNBC). My goal is to uncover novel therapeutic targets and metabolic signatures that can lead to more effective treatment strategies for TNBC.

Membership of professional bodies

Qualifications

Recent conferences

International experience

Additional interests and activities

Recent publications